Click image to enlarge
U-PLEX Combos offer popular panels of biomarkers that have been grouped together for convenient ordering. They have been tested for multiplex compatibility and are fulfilled as a kit. The U-PLEX Angiogenesis Combo 1 (human) combines 5 analytes (Table 1) that are associated with angiogenesis and tumor growth. The assays can be used for quantitative measurements of the sample type(s) listed in the "Specifications" tab below, and offer detection limits (LLODs) in the sub- to low pg/mL range. This Combo is provided on 2 plates.
| Analyte | LLOD - ULOD | Unit |
| FGF (basic) | 2.1 - 1,200 | pg/mL |
| PlGF | 0.19 - 1,200 | pg/mL |
| Tie-2 | 2.9 - 29,000 | pg/mL |
| VEGF-A | 2.0 - 4,900 | pg/mL |
| VEGF-D | 0.30 - 1,500 | pg/mL |
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
|
Application(s)
|
|
Cardiovascular
|
|
|
Analyte(s)
|
|
FGF (basic), PlGF, Tie-2, VEGF-A, VEGF-D
|
|
|
Species
|
|
Human
|
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
MESO QuickPlex SQ 120MM
,
MESO SECTOR S 600
,
SECTOR Imager 6000
,
MESO SECTOR S 600MM
,
MESO QuickPlex SQ 120
|
|
|
U-PLEX Group Compatibility
|
|
Immuno-Oncology Group 1
|
|
|
Plate Type
|
|
96-well
|
|
|
Sample Type
|
|
Plasma, Serum
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Statement(s)
|
|
Please refer to the product insert for the storage conditions of individual kit components.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Schedule B Code
|
|
3822.19.0000
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Human Angiogenesis Combo 1, Box 1 of 2 (1 PL)
|
Multi-Component
|
1 each
(1 each)
|
|
|
|
Human Angiogenesis Combo 1, Box 2 of 2 (1 PL)
|
Multi-Component
|
1 each
(1 each)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Human Angiogenesis Combo 1, Box 1 of 2 (5 PL)
|
Multi-Component
|
1 each
(5 each)
|
|
|
|
Human Angiogenesis Combo 1, Box 2 of 2 (5 PL)
|
Multi-Component
|
1 each
(5 each)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Human Angiogenesis Combo 1, Box 1 of 2 (25 PL)
|
Multi-Component
|
1 each
(25 each)
|
|
|
|
Human Angiogenesis Combo 1, Box 2 of 2 (25 PL)
|
Multi-Component
|
1 each
(25 each)
|
|
|
|
Product Inserts
|
|
|
|
Datasheets
|
|
|
|
Product Highlights
|
|
|
|
SDS
|
|
|
|
Title
|
Journal
|
Year
|
|
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
|
|
|
|
Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial
|
|
|
|
A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2 in patients with advanced hepatocellular cancer.
|
|
|
|
Phase I study of Dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinoma.
|
|
|
|
Effects of Sorafenib on Intra-Tumoral Interstitial Fluid Pressure and Circulating Biomarkers in Patients with Refractory Sarcomas (NCI Protocol 6948).
|
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters